Wexford Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,851
| Closed | -$502K | – | 199 |
|
|
2022
Q4 | $502K | Buy |
+5,851
| New | +$502K | 0.1% | 77 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$29K | – | 259 |
|
|
2020
Q4 | $29K | Hold |
500
| – | – | ﹤0.01% | 294 |
|
|
2020
Q3 | $32K | Sell |
500
-4,500
| -90% | -$288K | 0.01% | 167 |
|
|
2020
Q2 | $385K | Sell |
5,000
-83,283
| -94% | -$6.41M | 0.1% | 84 |
|
|
2020
Q1 | $6.6M | Buy |
+88,283
| New | +$6.6M | 2.44% | 9 |
|
|
2017
Q3 | – | Sell |
-5,200
| Closed | -$368K | – | 166 |
|
|
2017
Q2 | $368K | Buy |
+5,200
| New | +$368K | 0.03% | 125 |
|
|
2016
Q2 | – | Sell |
-54,026
| Closed | -$4.96M | – | 122 |
|
|
2016
Q1 | $4.96M | Buy |
54,026
+29,738
| +122% | +$2.73M | 0.97% | 38 |
|
|
2015
Q4 | $2.46M | Sell |
24,288
-16,468
| -40% | -$1.67M | 0.58% | 42 |
|
|
2015
Q3 | $4M | Buy |
+40,756
| New | +$4M | 0.77% | 43 |
|
|
2015
Q1 | – | Sell |
-204,870
| Closed | -$19.3M | – | 69 |
|
|
2014
Q4 | $19.3M | Buy |
204,870
+195,870
| +2,176% | +$18.5M | 3.72% | 4 |
|
|
2014
Q3 | $958K | Sell |
9,000
-211,819
| -96% | -$22.5M | 0.09% | 80 |
|
|
2014
Q2 | $18.3M | Buy |
220,819
+205,819
| +1,372% | +$17.1M | 1.36% | 6 |
|
|
2014
Q1 | $1.06M | Sell |
15,000
-10,000
| -40% | -$709K | 0.08% | 108 |
|
|
2013
Q4 | $1.88M | Sell |
25,000
-221,621
| -90% | -$16.6M | 0.16% | 81 |
|
|
2013
Q3 | $15.5M | Sell |
246,621
-44,160
| -15% | -$2.78M | 1.28% | 7 |
|
|
2013
Q2 | $14.9M | Buy |
+290,781
| New | +$14.9M | 1.31% | 8 |
|